Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business

Wait Pausing Investments

Johnson & Johnson is an American multinational corporation that develops medical devices, pharmaceuticals, and consumer packaged goods. Johnson & Johnson's pharmaceutical arm is Janssen Pharmaceuticals. The company announced in November 2021 that it would split into two publicly traded companies: one focused on consumer products and the other on pharmaceuticals and medical technologies.

Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business

Wait Pausing Investments

Global 500, is an annual ranking of the top 500 corporations worldwide

Global 500

Top 100 largest companies in Russia by revenue

Top 100
Revenue, mln.USD
1078
Staff
1675
Capital, mln.USD
749
Taxes, mln.USD
204
Glob.Revenue, mln.USD
93775
Assets, mln.USD
889

The company has three regional offices.

The Company Statement
January 28, 2022

The company suspended all advertising, enrollment in clinical trials, and any additional investment in Russia. It was decided to suspend supply of the personal care products in Russia. The company will continue to supply the medicines and medical devices in the region.

https://www.bloomberg.com/news/articles/2022-03-29/j-j-halts-supply-of-personal-care-products-in-russia
March 31, 2022https://www.jnj.com/johnson-johnson-statement-on-conflict-in-ukraine
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.